| DC Field | Value | Language |
|---|
| dc.contributor.author | Taran, Natalia | |
| dc.contributor.author | Dumbrava, Vlada-Tatiana | |
| dc.contributor.author | Tofan-Scutaru, Liudmila | |
| dc.date.accessioned | 2019-12-09T16:12:22Z | |
| dc.date.available | 2019-12-09T16:12:22Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | TARAN, Natalia, DUMBRAVA, Vlada-Tatiana, TOFAN-SCUTARU, Liudmila. Hepatocarcinomul celular: răspândire, factori de risc şi obţiuni de tratament. In: Sănătate Publică, Economie şi Management în Medicină. 2014, nr. 5(56), pp. 138-142. ISSN 1729-8687. | en_US |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/7241 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/05/cm5_56_2014.pdf | |
| dc.description | Universitatea de Stat de Medicină şi Farmacie
Nicolae Testemiţanu, Departamentul Medicină Internă,
Laboratorul Gastroentorologie,
Universitatea de Stat de Medicină şi Farmacie
N. Testemiţanu, Departamentul Medicină Internă,
Disciplina Gastroenterologie, Conferinţa Naţională de Gastroenterologie și Hepatologie cu participare internaţională 20 iunie 2014 Chişinău, Republica Moldova | en_US |
| dc.description.abstract | Liver cancer ranks the 6th place in the structure of oncological morbidity (749000 new cases) and third in cancer mortality structure (692000), representing 7% of all cancer cases. HCC represents more than 90% of primary liver cancer, being the primordial public health problem worldwide. Globally, approximately 54% of HCC cases causally relate to viral hepatitis B (400 million people), 31% of cases are caused by viral hepatitis C (170 million people infected) and the rest – 15% have other causes. The basic treatment of HCC is surgical. When properly selected, candidates resection and liver transplantation offers the best option for development (5-year survival rate is achieved in 60-80% of cases) and there are methods of choice in patients with early-stage tumors. | en_US |
| dc.description.abstract | Рак печени занимает 6-е место в структуре онкологической заболеваемости (749000 новых случаев) и 3-е место в структуре онкологической смертности (692000 случаев) и составляет 7% всех случаев рака. На ГЦК приходится более 90% первичных раковых опухолей печени, что представляет большую проблему здравоохранения во всем мире. В мире около 54% случаев ГЦК связаны с гепатитом В (им страдает 400 млн. человек), 31% случаев обусловлены гепатитом С (им заражено 170 млн. человек), а остальные 15% приходятся на другие причины. Основное лечение ГЦК — хирургическое. У хорошо подобранных кандидатов резекция и трансплантация печени обеспечивают наилучшие исходы (5-летняя выживаемость достигает 60–80%) и служат методом выбора у пациентов с ранней стадией опухоли. | |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească ”Economie, Management și Psihologie în Medicină” din Republica Moldova | en_US |
| dc.subject | viral chronic hepatitis | en_US |
| dc.subject | liver cirrhosis | en_US |
| dc.subject | liver transplantation | en_US |
| dc.subject | hepatocellular carcinoma | en_US |
| dc.subject | risk factors | en_US |
| dc.subject | treatment methods | en_US |
| dc.subject.mesh | Risk Factors | en_US |
| dc.subject.mesh | Carcinoma, Hepatocellular--diagnosis | en_US |
| dc.subject.mesh | Carcinoma, Hepatocellular--physiopathology | en_US |
| dc.subject.mesh | Carcinoma, Hepatocellular--epidemiology | en_US |
| dc.subject.mesh | Carcinoma, Hepatocellular--therapy | en_US |
| dc.subject.mesh | Carcinoma, Hepatocellular--drug therapy | en_US |
| dc.title | Hepatocarcinomul celular: răspândire, factori de risc şi obţiuni de tratament | en_US |
| dc.title.alternative | Hepatocellular carcinoma: spreading, risk factors and treatment options | en_US |
| dc.title.alternative | Гепатоцелюлярная карцинома: распространенность, факторы риска и варианты лечения | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Sănătate Publică, Economie şi Management în Medicină Nr. 5 (56) / 2014
|
